Evaluation of a new immunoassay for chromogranin A measurement on the Kryptor system

por van der Knaap, R.H.P., Kwekkeboom, D.J., Ramakers, C.R.B., de Rijke, Y.B.
Publicado 2015

Lutetium-labelled peptides for therapy of neuroendocrine tumours

por Kam, B. L. R., Teunissen, J. J. M., Krenning, E. P., de Herder, W. W., Khan, S., van Vliet, E. I., Kwekkeboom, D. J.
Publicado 2012

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

por Zaknun, John J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., Kwekkeboom, D. J.
Publicado 2013

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

por Bodei, L., Mueller-Brand, J., Baum, R. P., Pavel, M. E., Hörsch, D., O’Dorisio, M. S., O’Dorisio, T. M., Howe, J. R., Cremonesi, M., Kwekkeboom, D. J., Zaknun, J. J.
Publicado 2013

Efficacy of adalimumab in sarcoidosis

por Kamphuis, LSJ, Lam-Tse, W K, Dik, W A, Bastiaans, J, van Biezen, P, van Daele, PLA, Kwekkeboom, D J, Kuijpers, RWAM, Baarsma, G S, van Hagen, P M, Hooijkaas, H, van Laar, JAM
Publicado 2010

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate

por Kwekkeboom, D. J., Bakker, W. H., Kam, B. L., Teunissen, J. J. M., Kooij, P. P. M., de Herder, W. W., Feelders, R. A., van Eijck, C. H. J., de Jong, M., Srinivasan, A., Erion, J. L., Krenning, E. P.
Publicado 2003